The ShorTrip trial found that short-course radiotherapy followed by FOLFOX and FOLFOXIRI improved pathological response rates ...

To better understand the optimal approach for these patients, Lai and colleagues analyzed data from 3792 individuals undergoing curative resection for locally advanced rectal cancer between ...

Stepping into one of Makati Medical Center’s (MakatiMed) state-of-the-art operating suites feels like entering the future of ...

A joint study between the Nursing School of North Henan Medical University (Xinxaing, China) and The First Affiliated Hospital of Harbin Medical University (Harbin, China) used gas chromatography–mass ...

Hecht, MD, discusses the phase 3 OrigAMI-3 trial for patients with recurrent, unresectable, or metastatic RAS/BRAF wild-type colorectal cancer.

"Wnt is overactive in colon and rectal cancer, so if we could block Wnt, the cancer would theoretically be cured. But, at the same time, the treatment would kill stem cells in the intestine and ...

Despite these recommendations, the optimal extent of surgical resection for advanced gallbladder cancer remains a matter of ongoing debate. While it is well recognized that outcomes for advanced ...

According to Rachael A. Safyan, MD, medical director of the Fred Hutch/UW Medicine HAI Pump Program, HAI is primarily for patients with metastatic colorectal cancer that has spread to the liver. Early ...

There were 16% fewer colon cancer cases and 28% fewer rectal cancer cases in the group prescribed GLP-1 receptor agonists. Observational studies like this cannot prove that the GLP-1 drugs caused ...